<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Parry, Nicola</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Betti, Emanuele</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Risedronate and Follow-up Quantitative Ultrasound Reduces Refracture in Osteoporosis</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-04-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">17-18</style></pages><abstract><style  face="normal" font="default" size="100%">This article presents results from a randomized trial demonstrating a reduction in subsequent fractures in patients with intertrochanteric fractures who were treated with risedronate and received follow-up care with quantitative ultrasound to monitor the existing fracture and bone status.</style></abstract><number><style face="normal" font="default" size="100%">2</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>